37663-43-7Relevant articles and documents
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide
Trapella, Claudio,Fischetti, Carmela,Pela', Michela,Lazzari, Ilaria,Guerrini, Remo,Calo', Girolamo,Rizzi, Anna,Camarda, Valeria,Lambert, David G.,McDonald, John,Regoli, Domenico,Salvadori, Severo
experimental part, p. 5080 - 5095 (2009/12/24)
Twelve derivatives of the nociceptin/orphanin FQ (N/OFQ) receptor (NOP) antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide (Comp 24) were synthesized and tested in binding experiments performed on CHOsu
SPIROPIPERIDINE GLYCINAMIDE DERIVATIVES
-
Page/Page column 19, (2008/12/06)
In particular, the present invention is concerned with compounds of the general formula (I) wherein X, Y and R1 to R10 are as described herein. The compounds are V1a receptor antagonists. The invention also relates to the manufacture of compounds of formula I, pharmaceutical compositions containing them and their use for the treatment of anxiety and depressive disorders and other diseases.
1,3-Dihydrospiro[isobenzofuran]s and derivatives thereof
-
, (2008/06/13)
Novel substituted 1,3-dihydrospiro[isobenzofuran]s and methods of preparing the same are described. These compounds are useful as tranquilizers, analgetic agents and intermediates therefor.